Search results
We’re helping unlock the potential of new therapies and treatments. By investing in innovators and developing new solutions to support them, we play a crucial role in evolving what pharmaceutical and biopharma therapies can do. See how we further innovation.
- Meet Our New Brand
Since our founder’s apprenticeship in 1871, Cencora has...
- Who We Are
Patients you can help, we can reach. With our comprehensive...
- Contact Us
Cencora replaces AmerisourceBergen as our new parent company...
- Careers
At Cencora, great people can develop meaningful careers in...
- What We Offer
Cencora navigates logistics complexities with care, from...
- Meet Our New Brand
Aug 30, 2023 · CONSHOHOCKEN, Pa. (August 30, 2023) – Cencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE: ABC), marking the latest stage of the company’s evolution as a leader in global pharmaceutical services.
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2] Services. They provide drug distribution and consulting related to medical business operations and patient services.
- AmerisourceBergen Corporation (2001–2023)
- Pharmaceutical
- 2001; 22 years ago (merger between AmeriSource Health and Bergen Brunswig)
- Public company
People also ask
Is cencora a Fortune 500 company?
Why did cencora donate $5 million to the AmerisourceBergen Foundation?
Is AmerisourceBergen still part of cencora?
We’re advancing pharmaceutical care as Cencora. In August 2023, we united all the companies and services of AmerisourceBergen in our common purpose to create healthier futures. We’re now accelerating positive outcomes for our customers and their patients under our new name, Cencora. Learn more about who we are.